scholarly journals Paralleling of Diagnostic Endeavor for Control of Mycobacterial Infections and Tuberculosis

Author(s):  
Athumani Msalale Lupindu ◽  
Erasto Vitus Mbugi ◽  
Jahash Nzalawahe and Abubakar Shaaban Hoza

2012 ◽  
Vol 43 (10) ◽  
pp. 8
Author(s):  
MICHELE G. SULLIVAN


Pneumologie ◽  
2011 ◽  
Vol 65 (12) ◽  
Author(s):  
F Behler ◽  
K Steinwede ◽  
R Maus ◽  
J Bohling ◽  
UA Maus




1993 ◽  
Vol 25 (5) ◽  
pp. 619-623 ◽  
Author(s):  
Nadja Heurlin ◽  
Björn Petrini


2016 ◽  
Vol 73 (6) ◽  
pp. 558-567 ◽  
Author(s):  
Xia Yu ◽  
Pengnian Liu ◽  
Guan Liu ◽  
Liping Zhao ◽  
Yanjie Hu ◽  
...  


npj Vaccines ◽  
2021 ◽  
Vol 6 (1) ◽  
Author(s):  
Junli Li ◽  
Lingjun Zhan ◽  
Chuan Qin

AbstractBacillus Calmette–Guérin (BCG), the only vaccine proven to be effective against tuberculosis (TB), is the most commonly used vaccine globally. In addition to its effects on mycobacterial diseases, an increasing amount of epidemiological and experimental evidence accumulated since its introduction in 1921 has shown that BCG also exerts non-specific effects against a number of diseases, such as non-mycobacterial infections, allergies and certain malignancies. Recent Corona Virus Disease 2019 (COVID-19) outbreak has put BCG, a classic vaccine with significant non-specific protection, into the spotlight again. This literature review briefly covers the diverse facets of BCG vaccine, providing new perspectives in terms of specific and non-specific protection mechanisms of this old, multifaceted, and controversial vaccine.



Hand Clinics ◽  
1989 ◽  
Vol 5 (4) ◽  
pp. 591-598
Author(s):  
Stephen F. Gunther ◽  
Charles S. Levy


1994 ◽  
pp. 331-350 ◽  
Author(s):  
Ralph H. Hruban ◽  
Grover M. Hutchins


Sign in / Sign up

Export Citation Format

Share Document